CN110066804A - A kind of aptamer with borax specific binding - Google Patents
A kind of aptamer with borax specific binding Download PDFInfo
- Publication number
- CN110066804A CN110066804A CN201910371568.7A CN201910371568A CN110066804A CN 110066804 A CN110066804 A CN 110066804A CN 201910371568 A CN201910371568 A CN 201910371568A CN 110066804 A CN110066804 A CN 110066804A
- Authority
- CN
- China
- Prior art keywords
- borax
- aptamer
- bor
- specific binding
- specifically bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 114
- 239000004328 sodium tetraborate Substances 0.000 title claims abstract description 102
- 229910021538 borax Inorganic materials 0.000 title claims abstract description 101
- 235000010339 sodium tetraborate Nutrition 0.000 title claims abstract description 101
- 230000009870 specific binding Effects 0.000 title claims abstract description 16
- 108020004414 DNA Proteins 0.000 claims abstract description 28
- 102000053602 DNA Human genes 0.000 claims abstract description 18
- 238000012216 screening Methods 0.000 claims abstract description 17
- 239000002773 nucleotide Substances 0.000 claims abstract description 16
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 16
- 108020004682 Single-Stranded DNA Proteins 0.000 claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 12
- 238000005516 engineering process Methods 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 28
- 238000012163 sequencing technique Methods 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 239000000427 antigen Substances 0.000 claims description 9
- 108091007433 antigens Proteins 0.000 claims description 9
- 102000036639 antigens Human genes 0.000 claims description 9
- 230000008878 coupling Effects 0.000 claims description 9
- 238000010168 coupling process Methods 0.000 claims description 9
- 238000005859 coupling reaction Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 108091034117 Oligonucleotide Proteins 0.000 claims description 7
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 4
- 238000012512 characterization method Methods 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000006978 adaptation Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 16
- 239000007788 liquid Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 24
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 22
- 239000000853 adhesive Substances 0.000 description 12
- 230000001070 adhesive effect Effects 0.000 description 12
- 229960002685 biotin Drugs 0.000 description 11
- 235000020958 biotin Nutrition 0.000 description 11
- 239000011616 biotin Substances 0.000 description 11
- 238000005406 washing Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 239000004327 boric acid Substances 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 6
- 241001349468 Elona Species 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 230000003321 amplification Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000010355 oscillation Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 244000163122 Curcuma domestica Species 0.000 description 3
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 125000005619 boric acid group Chemical group 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 238000002983 circular dichroism Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 235000003373 curcuma longa Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 150000001639 boron compounds Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 229940043267 rhodamine b Drugs 0.000 description 2
- XWGJFPHUCFXLBL-UHFFFAOYSA-M rongalite Chemical compound [Na+].OCS([O-])=O XWGJFPHUCFXLBL-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GUYIZQZWDFCUTA-UHFFFAOYSA-N (pentadecachlorophthalocyaninato(2-))-copper Chemical compound [Cu+2].N1=C([N-]2)C3=C(Cl)C(Cl)=C(Cl)C(Cl)=C3C2=NC(C2=C(Cl)C(Cl)=C(Cl)C(Cl)=C22)=NC2=NC(C2=C(Cl)C(Cl)=C(Cl)C(Cl)=C22)=NC2=NC2=C(C(Cl)=C(C(Cl)=C3)Cl)C3=C1[N-]2 GUYIZQZWDFCUTA-UHFFFAOYSA-N 0.000 description 1
- XGIKILRODBEJIL-UHFFFAOYSA-N 1-(ethylamino)ethanol Chemical compound CCNC(C)O XGIKILRODBEJIL-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 206010051290 Central nervous system lesion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 229910004835 Na2B4O7 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002117 illicit drug Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 108091008104 nucleic acid aptamers Proteins 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to field of biomedicine technology more particularly to a kind of aptamers with borax specific binding, and the aptamer nucleotide sequence with borax specific binding is as shown in SEQ ID NO:1;The aptamer is single stranded DNA, is made of 82 nucleotide, topology is straight-chain;The secondary structure of prediction has ring outstanding and stem, Gibbs free energy DG=-15.21.The present invention is capable of the identification of high-affinity high specific using the aptamer Bor-A01 that SELEX technology screening goes out and combines borax;Detection of the identification of aptamer Bor-A01 for borax remaining in food, and then reduce borax and be of great significance to the infringement of human body.
Description
Technical field
The invention belongs to field of biomedicine technology more particularly to a kind of aptamers with borax specific binding.
Background technique
Currently, the immediate prior art:
Aptamer is by index concentration Fas lignand system evolution technology (SyStematic evolution of
LigandS by exponential enrichment, SELEX) screening obtain can be big with metal ion, small molecule, biology
Molecule, or even the SSDNA or RNA molecule of the entire high specificity of cell and compatibility combination.Aptamer not only has antibody
The evident characteristics of molecule, it is all to be related to the diagnostic field of antibody, it can nearly all be replaced with aptamer, and be also equipped with
Oneself unique excellent properties, with target molecule range is wide, molecular mass is small, immunogenicity is low, is easy to chemical synthesis, transformation
The advantages that with label.Aptamer and its related screening technique (SELEX), aptamer is in recent years in treatment new drug, medicine
In the fields of biomedicine such as object transport, cancer cell detection, bio-imaging, the discovery of biomarker, illicit drugs inspection, antiviral
Using.
Borax, generally writing Na2B4O7·10H2O is very important containing boron mineral and boron compound, usually colourless
The white powder of crystal, it is soluble easily in water.Borax can be used as detergent, cosmetics, insecticide, it can also be used to configure buffer solution and
Produce other boron compounds etc..The toxicity of borax is higher, is a kind of strong carcinogen, to the stomach of human body, kidney, liver, brain and
Skin lesion is very big, and the adult toxic dose of borax is 1-3 grams, and adult lethal dose is 15 grams, and baby's lethal dose is 2-3 grams.People
If body takes in excessive borax, the retention toxicosis of multi viscera can be caused.Long-term Excess free enthalpy borax, to human body reproduction, development
With the toxic influence of endocrine system.Short time takes in large dosage of borax, may cause acute poisoning, and less serious case causes dizzy, head
Bitterly, the symptoms such as loss of appetite, indigestion, weight loss;There are the poisoning manifestations such as vomiting, diarrhea, shock, stupor in serious person.
There is non-specific lesion in the visible stomach of the pathologic finding of borax poisoner, kidney, liver, brain and skin, mainly have liver it is congested,
Steatosis, liver cell cloudy swelling;Kidney is in diffusivity oedema, and glomerulus and renal tubule have damage;There is oedema in brain and lung.
The illegal producer and retailer are in order to increase the toughness, brittleness mouthfeel or extended shelf life of food, often in the processing of food
Illegal addition borax in the process.Since the strong carcinogenicity of borax and more virulent property, countries in the world generally forbid making an addition to borax
In food, prohibites in China " food hygiene law " and " food additives administration of health method " and added borax as food
Agent uses.
It is at present turmeric colorimetric method for detection borax main method in food.The method needs first in acid condition by boron
Sand is changed into boric acid, extrapolates the additive amount of borax indirectly by detecting the content of boric acid.Due to the souring operation of early period, this
The result of kind detection method has certain deviation, and testing result can only indicate there is boric acid in food, not necessarily directly
It connects and is added to borax.Therefore, in order to ensure that the health of broad masses of the people, is established a kind of accurate and reliable, sensitive quick, extensive
The method of borax is particularly important in applicable detection food.
In conclusion problem of the existing technology is:
At present for borax turmeric colorimetric method is detected in food, as a result there is certain deviation, and testing result can only table
Show there is boric acid in food, is not necessarily directly added to borax.Foundation cannot be provided to borax in detection food.
Summary of the invention
In view of the problems of the existing technology, the present invention provides a kind of aptamers with borax specific binding.
The invention is realized in this way a kind of aptamer with borax specific binding, described specific with borax
In conjunction with aptamer nucleotide sequence as shown in SEQ ID NO:1;The aptamer is single stranded DNA, by 82 nucleosides
Acid composition, topology is straight-chain.
Further, the secondary structure of prediction has ring outstanding and stem, Gibbs free energy DG=-15.21.
Another object of the present invention is to provide a kind of screening techniques with the aptamer of borax specific binding to adopt
With SELEX technology screening go out can with borax specifically bind aptamer group, design primer carry out PCR amplification, gram
Grand, separation and sequencing;It is verified using enzyme-linked oligonucleotides adsorption experiment, obtains aptamers Bor-A01.
Further, the adapter-primer sequence of aptamers are as follows: Aptamer Fw:GACATATTCAGTCTGACAGC;Reverse mutual
Complementary series: CGCTGTCAGACTGAATATGTC;Aptamer Rv:GCTAGACGATATTCGTCCATC, reverse complementary sequence:
GATGGACGAATATCGTCTAGC;Obtained positive monoclonal carries out nucleotide sequencing, and sequencing result shows special with borax
Property the aptamer that combines be made of 82 nucleotide, 5 ' ends are to 3 ' terminal sequences are as follows:
GACATATTCAGTCTGACAGCGGAAGCGGGTCAGTCCAACTCACGGTCTCGCATGCACGGGAGATGGAC
GAATATCGTCTAGC。
Further, it also needs to carry out aptamer single stranded DNA secondary structure characterization after obtaining aptamers Bor-A01,
Second level is carried out using the aptamer Bor-A01 single strand dna that MFOLD software pair is specifically bound with borax
Structure prediction;Secondary structure has ring outstanding and stem, Gibbs free energy DG=-15.21
Further, the preparation of borax coating antigen includes:
The coating antigen that borax molecule and BSA coupling are obtained to borax by chemical method, is used for subsequent enzyme-linked oligonucleotides
In adsorption measurement;The preparation situation of coating antigen is judged by ultra-violet absorption spectrum.
Another object of the present invention is to provide a kind of aptamers for being loaded with the specific binding of described and borax
In identification borax or in the kit of preparation detection borax.
In conclusion advantages of the present invention and good effect are as follows:
The present invention obtains the aptamer Bor-A01 specifically bound with borax using SELEX technology screening, described
Aptamer is single stranded DNA, is made of 82 nucleotide, and nucleotide sequence is as shown in SEQ ID NO:1;Its secondary structure
Containing ring outstanding and stem, wherein Bor-A01 Gibbs free energy DG=-15.21.Based on enzyme-linked oligonucleotides adsorption measurement
The a series of properties assessment such as aptamer specificity, affinity and sensitivity is carried out, shows Bor-A01 dissociation constant Kd=
22.08 ± 2.730nM, and can be specific in conjunction with borax, therefore the aptamer has the spy of high specific, high-affinity
Point can be used in the application of the subsequent quick detection kit to borax.
The present invention is capable of the knowledge of high-affinity high specific using the aptamer Bor-A01 that SELEX technology screening goes out
Not and combine borax;Detection of the identification of aptamer Bor-A01 for borax remaining in food, and then reduce borax pair
The infringement of human body is of great significance.
Detailed description of the invention
Fig. 1 is the secondary structure schematic diagram provided in an embodiment of the present invention for aptamer Bor-A01.
Fig. 2 be it is provided in an embodiment of the present invention the present invention in circular dichroism detector to K+Concentration and aptamer Bor-A01
The analysis result of structural relation;
Fig. 3 is the uv absorption spectra of boric acid-BSA conjugate provided in an embodiment of the present invention;
Fig. 4 is that ELONA method divides the specificity of aptamer Bor-A01 in the present invention provided in an embodiment of the present invention
It analyses, in figure: blank control: defatted milk;Negative control is non-target substance: rhodamine B, acephatemet, sodium formaldehyde sulfoxylate, boric acid;It is positive
Group: borax;
Fig. 5 is that ELONA method divides the affinity of aptamer Bor-A01 in the present invention provided in an embodiment of the present invention
Analysis, the affinity K of the combination of aptamer Bor-A01 and boraxdValue indicates.
Fig. 6 is sensitive to borax based on ELONA method aptamer Bor-A01 in the present invention provided in an embodiment of the present invention
The analysis of degree, in figure: blank control: defatted milk;Positive group: borax;
Fig. 7 is the secondary structure figure of the aptamer Bor-A01 after different loci provided in an embodiment of the present invention truncates;
Fig. 8 is truncation experiment point of the ELONA method to aptamer Bor-A01 in the present invention provided in an embodiment of the present invention
It analyses, in figure: blank control CK1: defatted milk;Blank control CK2: biotin;Positive group: being marked with the aptamers Bor- of biotin
A01 and truncation aptamers Bor-A1279, Bor-A1263, Bor-A3879, Bor-A1234, the Bor- for being marked with biotin
A3863、Bor-A6579。
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to
Limit the present invention.
At present for borax turmeric colorimetric method is detected in food, as a result there is certain deviation, and testing result can only table
Show there is boric acid in food, is not necessarily directly added to borax.Foundation cannot be provided to borax in detection food.
To solve the above problems, below with reference to concrete scheme, the present invention is described in detail.
Aptamer nucleotide sequence such as SEQ ID NO:1 provided in an embodiment of the present invention with borax specific binding
It is shown;The aptamer is single stranded DNA, is made of 82 nucleotide, topology is straight-chain.
The secondary structure of prediction has ring outstanding and stem, Gibbs free energy DG=-15.21.
Another object of the present invention is to provide a kind of screening techniques with the aptamer of borax specific binding to adopt
With SELEX technology screening go out can with borax specifically bind aptamer group, design primer carry out PCR amplification, gram
Grand, separation and sequencing;It is verified using enzyme-linked oligonucleotides adsorption experiment, obtains aptamers Bor-A01.
The adapter-primer sequence of aptamers are as follows:
AptamerFw:GACATATTCAGTCTGACAGC;
Reverse complementary sequence: CGCTGTCAGACTGAATATGTC;
Aptamer Rv:GCTAGACGATATTCGTCCATC,
Reverse complementary sequence: GATGGACGAATATCGTCTAGC;Obtained positive monoclonal carries out nucleotide sequencing,
Sequencing result shows that the aptamer specifically bound with borax is made of 82 nucleotide, 5 ' ends to 3 ' terminal sequences are as follows:
GACATATTCAGTCTGACAGCGGAAGCGGGTCAGTCCAACTCACGGTCTCGCATGCACGGGAGATGGAC
GAATATCGTCTAGC。
It also needs to carry out aptamer single stranded DNA secondary structure characterization after obtaining aptamers Bor-A01,
Second level is carried out using the aptamer Bor-A01 single strand dna that MFOLD software pair is specifically bound with borax
Structure prediction;Secondary structure has ring outstanding and stem, Gibbs free energy DG=-15.21
The preparation of borax coating antigen includes:
The coating antigen that borax molecule and BSA coupling are obtained to borax by chemical method, is used for subsequent enzyme-linked oligonucleotides
In adsorption measurement;The preparation situation of coating antigen is judged by ultra-violet absorption spectrum.
The invention will be further described combined with specific embodiments below.
Embodiment 1: the screening of borax aptamer
One, the coupling of aglucon (borax) and matrix (Ago-Gel 6B)
1, in sintered glass filter (more reciprocal of duty cycle G3) with the freeze-dried powder Ago-Gel of suspension 1g in 3mL distilled water
6B;
2, the coupling buffer solution (carbonate buffer of 0.05M, pH9.6 of 200mL is used in sintered glass filter immediately
Liquid) washing matrix 1 hour;-
3, with the aglucon of the coupling buffer solution dissolution 6g of 6mL, make its ultimate density 1mg/mL;
It 4, is that 1mg/mL has dissolved the buffer solution of aglucon 1:2 ratio by volume by the concentration in step 2 matrix and step 3
Example mixing is handled 16 hours under 35 DEG C -40 DEG C of water bath condition, and 37 DEG C of shaking tables are stayed overnight;
5, under conditions of 40 DEG C -50 DEG C, with the superfluous group of the ethylaminoethanol of 1M closing, at least 4 hours or overnight;
6, surplus aglucon is washed with coupling buffer, 4000rpm is centrifuged 2 minutes, draws supernatant;With ultrapure water (each 7-
8mL) clean 3 times;And then it uses and contains 0.1M NaHCO3, 0.5M NaCl pH8.0 solution clean 3-4 times;Then with containing
Have 0.1M NaCl, 0.1M acetate pH 4.0 solution clean 3-4 times;It is finally 20% ethyl alcohol with mass percent concentration
6mL is saved, and is placed in 4 DEG C of refrigerators, and sealed membrane sealing is vertical to place.
Two, the PCR of aptamer library (ssDNA)
The ssDNA aptamers library synthesized using TaKaRa company;
1,94 DEG C of preheating PCR instruments;
2, by 3 μ L ssDNA, 30.6 μ L deionized waters, 5 μ L10 × Buffer, 3 μ LMgCl2, 4 μ L dNTP mixtures it is (each
2.5 μM), 2 μ L forward direction amplimers, the reversed amplimer of 2 μ L and 0.4 μ L Taq enzyme centrifuge tube reacted;Forward direction amplification
Primer sequence is 5 '-GACATATTCAGTCTGACAGC-3 ', and reversed amplimer sequence is 5 '-
GCTAGACGATATTCGTCCATC-3’。
3, it is expanded in PCR instrument by following procedure
(1) initial denaturation
94 DEG C 5 minutes;
(2) 30 circulations
94 DEG C 45 seconds
58 DEG C 30 seconds
72 DEG C 30 seconds;
(3) it expands afterwards
72 DEG C 7 minutes.
Three, the purifying in ligand library, loading and elution
1, the purifying in ligand library
(1) directly 1:1 ratio is mixed by volume with the solution in plastic recovery kit for aptamer library PCR product
It closes, carries out DNA fragmentation recycling;
(2) DNA fragmentation recycling after, 95 DEG C water-bath 10 minutes, ice bath 10 minutes;By this denaturation treatment, become double-stranded DNA
At single stranded DNA.
2, affinity chromatography
(1) matrix that was coupled being eluted with coupling buffer: drawing upper solution, coupling buffer is added to mix to 6mL,
Centrifugation, discards supernatant liquid, this step is repeated 3 times;
(2) single stranded DNA in step 1 is added in the matrix being coupled, is incubated in 37 DEG C and 40rpm softly rotates 2
Hour;
(3) aforementioned sample is added into chromatographic column, with the ultrapure water pillar of 2-3 column volume;
(4) linear ladder then is carried out with the elution buffer (0.1M NaCl, 0.1M acetate, pH4.0) of 3-4 column volume
Degree elution, collects elution fraction;
(5) elution fraction mixes in equal volume with sol solution, is dissolved after recycling with TE solution, obtains Selex solution.
Four, PCR optimization and massive amplification aptamer
Using above-mentioned Selex solution as template, operate as follows:
1,94 DEG C of preheating PCR instruments;
2, by 5 μ L templates, 28.6 μ L deionized waters, 5 μ L10 × Buffer, 3 μ LMgCl2, 4 μ L dNTP mixtures it is (each
2.5 μM), 2 μ L forward direction amplimers, the reversed amplimer of 2 μ L, 0.4 μ LTaq enzyme, reacted in PCR centrifuge tube.It is positive
Amplimer sequence is 5 '-GACATATTCAGTCTGACAGC-3 ', and reversed amplimer sequence is 5 '-
GCTAGACGATATTCGTCCATC-3’。
3, it is expanded in PCR instrument by following procedure:
(1) initial denaturation
94 DEG C 5 minutes;
(2) 32 circulations:
94 DEG C 45 seconds
58 DEG C 30 seconds
72 DEG C 30 seconds;
(3) it expands afterwards
72 DEG C 7 minutes;
4, PCR product after circulation terminates, is stripped recycling with the DNA product purification kit of TIANGEN company, is walked
It is rapid as follows:
(1) PCR product and isometric colloidal sol buffer are mixed by inversion, mixed liquor are then transferred to centrifugal purification column,
It is stored at room temperature 5 minutes, makes DNA sufficiently in conjunction with pellosil, 12000rpm is centrifuged 1 minute, outwells the waste liquid in collecting pipe;
(2) rinsing liquid (containing ethyl alcohol) of 700 μ L is added in centrifugal purification column, 12000rpm is centrifuged 1 minute, outwells collection
Waste liquid in pipe;
(3) step (2) are repeated;
(4) 12000rpm is centrifuged 3 minutes;
(5) centrifugal purification column is placed in new centrifuge tube;
(6) 30 μ L ultrapure waters are added, stand 5 minutes at room temperature;
(7) 12000rpm is centrifuged 1 minute, and tube bottom solution is the PCR product of the aptamer purified.
Embodiment 2: the clone of aptamer, separation and sequencing and the prediction of single stranded DNA secondary structure
One, the preparation of bacillus coli DH 5 alpha competent cell
1, the single DH5 α bacterium colony of picking is inoculated in 3mL LB culture medium not with ampicillin, 37 DEG C of overnight incubations,
Next day takes above-mentioned bacterium solution, and 1:100 is inoculated in 50mL LB liquid medium in proportion, and 37 DEG C vibrate 2 minutes;When OD600 value reaches
When to 0.35, bacterial cultures is harvested;
2, bacterial cultures is transferred in the sterile polypropylene tube of 50mL pre-cooling, places 10 minutes on ice, makes to train
It is cooling to support object;
3,4000rpm is centrifuged 10 minutes at 4 DEG C, discards culture solution, and pipe is inverted l/min so that remaining culture solution
It flows to end;
4, respectively add the 0.1mM CaCl of 150 μ L ice pre-cooling2Solution merges two and manages, and ice bath 10 minutes;
5,4000rpm is centrifuged 10 minutes at 4 DEG C, discards supernatant liquid, and pipe is inverted l/min so that residual liquid stream
To the greatest extent;
6, the 0.1M CaCl of 800 μ L ice pre-cooling is first added2Cell is resuspended in solution, adds the sweet of the 75% of 25 μ L pre-cooling
Oil, it is spare in -80 DEG C of storages later.
Two, connection and the conversion of connection product
1,0.5 μ LTakarapMD19-T Simple carrier, 4.5 μ L aptamer PCR are added in microcentrifugal tube
The ligase buffer mixture of product and 5 μ L;
2, it reacts 3 minutes for 16 DEG C;
3, full dose (10 μ L) is added into 100 μ L DH5 α competent cells, places 30 minutes in ice;
4,42 DEG C after heating 90 seconds, then place 1 minute in ice;
5, the LB culture medium 890 μ L for being added that 37 DEG C of warm bath cross, 37 DEG C slow oscillation culture 60 minutes;
6, take 200 μ L be coated on containing X-Gal, IPTG, ampicillin LB culture medium on, 37 DEG C culture 16 hours with
Form single colonie.
Three, the colony screening of aptamer, separation and sequencing and single stranded DNA secondary structure prediction
The single bacterium of the above-mentioned white of picking is fallen in LB culture medium with ampicillin, 37 DEG C slow oscillation culture 4 hours,
Carry out PCR amplification;The amplification condition of amplimer and amplification condition with aforementioned aptamer.Positive gram will confirmed through PCR
After grand progress plasmid extraction, nucleosides is carried out with the full-automatic nucleotide sequencing instrument of U.S. Applied BioSyStemS3730A
The measurement of acid sequence;Structure shows its sequence of aptamer specifically bound with borax from 5 ' ends to 3 ' ends are as follows:
GACATATTCAGTCTGACAGCGGAAGCGGGTCAGTCCAACTCACGGTCTCGCATGCACGGGAGATGGACG
AATATCGTCTAGC
The sequence length of the aptamer Bor-A01 specifically bound with borax: 82 bases, sequence type: nucleic acid,
Chain number: single-stranded, topology: straight-chain, sequence type: ssDNA.
It is 26 DEG C, Na that temperature, which is arranged, by MFOLD software+Concentration is 150mM, Mg2+Concentration be 1mM (http: //
Mfold.rna.albany.edu/? q=mfold/DNA-Folding-Form) and QGRS mapping (http: //
BioinformaticS.ramapo.edu/QGRS/analyze.php) to the aptamer Bor- specifically bound with borax
A01 single strand dna carries out secondary structure prediction.The result shows that aptamers contain ring and stem outstanding, Bor-A01 gibbs
Free energy DG=-15.21;Structure stability with higher (see Fig. 1).
Embodiment 3: circular dichroism detector (CD) is to K+Concentration is probed into aptamer Bor-A01 structural relation
1, by aptamer ddH2O is diluted to 20 μM, after 95 DEG C of denaturation 30s, is cooled to 25 DEG C rapidly.Again
The aptamer after above-mentioned denaturation is diluted to 2.5 μ with the KCl solution of various concentration (0,10,20,40,60,80,100mM)
M。
2, aptamer is diluted to 20 μM with 10mM PBS, after 95 DEG C of denaturation 30s, is cooled to 25 rapidly
DEG C, then 2.5 μM are diluted to 10mM PBS.
3, temperature setting is 25 DEG C, is detected with circular dichroism spectrometer, wherein the scanning wavelength set is 220-340nm;
Scanning speed is 100nm/min;Reaction time is 1s.
The result shows that: in various concentration K+Under environment, the positivity band of the CD map of aptamers Bor-A01 is both present in
Near 280nm, negativity band is both present near 245nm, is intersected near 260nm with b axis, complies with standard the CD figure of DNA
Spectrum.And the fluctuating range of each curve is unobvious, therefore aptamer Bor-A01 can be stabilized simultaneously in KCl solution
And it will not influence its secondary structure (see Fig. 2).
Embodiment 4: borax-BSA conjugate preparation
1,2mg borax is dissolved with 0.2mL dimethylformamide (DMF), A liquid is made.
2,5mg BSA, 3mg EDPC addition 25mL ultrapure water are dissolved, B liquid is made.
3, A liquid is gradually added drop-wise in B liquid, stirring while adding, 1mg EDPC after 10min, in room temperature, the item that pH is 5.5
Continue to stir 18h under part.
4, it with PBS solution dialysis 3d, changes the liquid once daily.After having dialysed, packing freeze-drying is saved.
The result shows that: with borax, BSA characteristic peak compared with, borax-BSA compound in 290nm, 434nm, 471nm,
There is different characteristic ultraviolet absorptions at 509nm, 549nm, shows that borax and BSA are coupled successfully (see Fig. 3).
Embodiment 5: specificity, affinity and the sensitivity to borax of aptamer Bor-A01
One, aptamer Bor-A01 specific detection
1, ELONA method
It is improved on the basis of traditional ELISA method, antibody is replaced with the aptamers screened, using life
Object element-Avidin amplification system is to detect sample to be tested.
(1) coating of toxin
9.6 carbonate buffer solution of 0.05M pH and borax volume ratio are 1:1 mixing, the final concentration of 1 μ g/mL of borax.Often
100 μ L of hole is added in ELISA Plate, is sealed with adhesive sticker, in being incubated for 2 hours on 37 DEG C, 100rpm oscillator, abandoning after being incubated for
The liquid in hole is removed, 200 μ L PBST cleaning solutions are added in every hole, oscillation washing 3 times on Yu Shuiping constant-temperature table, 2 points of washing every time
It is patted dry after clock on clean blotting paper.Blank control and negative control (blank control: defatted milk are set up simultaneously;Negative control
For non-target substance: rhodamine B, acephatemet, sodium formaldehyde sulfoxylate, boric acid;Positive group: borax.Concentration is consistent, and method is same as above).
(2) it closes
In the ELISA Plate for being coated with borax toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker, it
Afterwards, in being incubated for 2 hours on 37 DEG C, 100rpm oscillator, after closing, liquid in hole is discarded, repeats the purge step in (1)
Suddenly.
(3) plus the aptamer with biotin labeling is incubated for
It screens the aptamer Bor-A01 for obtaining to combine with borax toxin and is sent to the conjunction of Shanghai Sheng Gong biotech firm
At, and Bor-A01 is marked with biotin (Biotin).In use, first carrying out of short duration centrifugation, make the nucleic acid of labeled biotin
Aptamers are all gathered in test tube bottom.It is with aqua sterilisa that the aptamer of labeled biotin is sufficiently molten according to explanation
Solution is 10 at concentration-4The storing solution of M can be packed as aliquot in order to avoid freeze thawing repeatedly.
The aptamer Bor-A01 of labeled biotin is diluted to the working concentration of 100nM with 1 × PBS, then,
Accordingly 100 μ L are added in each hole, after adhesive sticker or sealed membrane sealing, in being incubated for 2 hours on 37 DEG C, 100rpm oscillator,
After incubation, liquid in hole is discarded, repeats the washing step in (1).
(4) enzyme conjugate is incubated for
The horseradish peroxidase conjugate that 100 μ L indicate Streptavidin is added in each hole, it is then, close with adhesive sticker
Envelope in being incubated for 1 hour on 37 DEG C, 100rpm oscillator, after incubation, discards liquid in hole, repeats the washing in (1) later
Step.
(5) it develops the color
100 μ L of color developing agent TMB solution is added in every hole, is protected from light colour developing 20 minutes at 37 DEG C later.
(6) it terminates
Finally, the terminate liquid (2M sulfuric acid) of 50 μ L is added into every hole, and to make within 10 minutes of reaction terminating
Absorbance value of each hole at 450nm is detected with microplate reader, obtains OD 450nm.
The results show that aptamers Bor-A01 can and borax specificity combination (see Fig. 4).
Two, the affinity K of aptamer Bor-A01dValue calculates:
1,9.6 carbonate buffer solution of 0.05M pH and borax volume ratio are 1:1 mixing, the final concentration of 1 μ g/mL of borax.
Every 100 μ L of hole is added in ELISA Plate, is sealed with adhesive sticker, in being incubated for 2 hours on 37 DEG C, 150rpm oscillator, after being incubated for
Discard liquid in hole, every hole adds 200 μ L of cleaning solution, on horizontal shaker oscillation washing 3 times, 2 minutes every time, similarly every time
It is to pat dry on net blotting paper;
2, in the ELISA Plate for being coated with borax toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker,
Later, in being incubated for 2 hours on 37 DEG C, 100rpm oscillator, after closing, liquid in hole is discarded, repeats the purge step in 1
Suddenly;
3, by the aptamers of biotin labeling with 1 × PBS be diluted to 1nM, 5nM, 10nM, 20nM, 50nM, 80nM,
100nM, 150nM, 300nM, 500nM, each hole adds 100 μ L, is sealed with adhesive sticker or sealed membrane, vibrates in 37 DEG C, 100rpm
It is incubated for 2 hours on device, liquid in hole is discarded after being incubated for, repeat the washing step in 1;
3,100 μ L horseradish peroxidase conjugates are added in every hole, are sealed with adhesive sticker, are vibrated in 37 DEG C, 150rpm
It is incubated for 1 hour on device, discards liquid in hole, repeat the washing step in 1;
4,100 μ L of TMB color developing agent is added in every hole, and colour developing 20 minutes is protected from light in 37 DEG C;
5, add 50 μ L terminate liquids (2M sulfuric acid), and surveyed at each hole 450nm and inhaled with microplate reader within reaction terminating 10 minutes
Shading value OD 450nm;
The result shows that the K of aptamer Bor-A01d=22.08 ± 2.730nM (see Fig. 5).
Four, detection of the aptamer Bor-A01 to borax sensitivity
1,9.6 carbonate buffer solution of 0.05M pH and borax volume ratio are 1:1 mixing, make the final concentration of 1ng/ of borax
ML, 5ng/mL, 10ng/mL, 20ng/mL, 40ng/mL, 60ng/mL, 80ng/mL, 100ng/mL.Every 100 μ L of hole is added to enzyme
It in target, is sealed with adhesive sticker, in being incubated for 2 hours on 37 DEG C, 150rpm oscillator, liquid in hole, every hole is discarded after being incubated for
Add 200 μ L of cleaning solution, in oscillation washing 3 times on horizontal shaker, 2 minutes every time, to be similarly net blotting paper every time
On pat dry;
2, in the ELISA Plate for being coated with borax toxin, 5% defatted milk of 100 μ L is added in each hole, is sealed with adhesive sticker,
Later, in being incubated for 2 hours on 37 DEG C, 100rpm oscillator, after closing, liquid in hole is discarded, repeats the purge step in 1
Suddenly;
3, the aptamers of biotin labeling are diluted to 100nM with 1 × PBS, each hole adds 100 μ L, with adhesive sticker or envelope
Membrana oralis sealing discards liquid in hole in being incubated for 2 hours on 37 DEG C, 100rpm oscillator after being incubated for, repeat the purge step in 1
Suddenly;
4,100 μ L horseradish peroxidase conjugates are added in every hole, are sealed with adhesive sticker, are vibrated in 37 DEG C, 150rpm
It is incubated for 1 hour on device, discards liquid in hole, repeat the washing step in 1;
5,100 μ L of TMB color developing agent is added in every hole, and colour developing 20 minutes is protected from light in 37 DEG C;
6, add 50 μ L terminate liquids (2M sulfuric acid), and surveyed at each hole 450nm and inhaled with microplate reader within reaction terminating 10 minutes
Shading value OD 450nm;
The result shows that aptamer Bor-A01 detects that the minimum concentration of borax is not 20ng/mL (see Fig. 6).
Embodiment 6: the truncation experimental analysis of aptamer Bor-A01
In order to reduce the cost of nucleic acid aptamers, to aptamer Bor-A01 be based on its secondary structural features into
Row truncates experiment and gropes.Sequence after aptamer truncates see the table below, and secondary structure is as shown in Figure 7.Six are truncated respectively
Aptamer segment and full length fragment afterwards carries out ELONA method and is verified, remaining operation is same as above.
The result shows that: the segment after truncation cannot identify target molecule, and therefore, aptamer Bor-A01 shows that it is complete
Three-dimensional structure be capable of the identification target molecule (Fig. 8) of high-affinity
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Made any modifications, equivalent replacements, and improvements etc., should all be included in the protection scope of the present invention within mind and principle.
Sequence table
<110>Kunming University of Science and Technology
<120>a kind of aptamer with borax specific binding
<130> 2018
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 82
<212> DNA
<213>artificial synthesized (artificial)
<400> 1
gacatattca gtctgacagc ggaagcgggt cagtccaact cacggtctcg catgcacggg 60
agatggacga atatcgtcta gc 82
Claims (7)
1. a kind of aptamer with borax specific binding, which is characterized in that the nucleic acid with borax specific binding
Aptamers nucleotide sequence is as shown in SEQ ID NO:1;The aptamer is single stranded DNA, is made of 82 nucleotide, topology
Structure is straight-chain.
2. the aptamer specifically bound as described in claim 1 with borax, which is characterized in that the secondary structure of prediction
With ring outstanding and stem, Gibbs free energy DG=-15.21.
3. a kind of screening technique with the aptamer of borax specific binding as described in claim 1, which is characterized in that
The screening technique with the aptamer of borax specific binding is gone out using SELEX technology screening can be with borax specificity
In conjunction with aptamer group, design primer carries out PCR amplification, clone, separation and sequencing;It is adsorbed using enzyme-linked oligonucleotides
It is verified, obtains aptamers Bor-A01.
4. the screening technique of the aptamer specifically bound as claimed in claim 3 with borax, which is characterized in that adaptation
The adapter-primer sequence of body are as follows: Aptamer Fw:GACATATTCAGTCTGACAGC;Reverse complementary sequence:
CGCTGTCAGACTGAATATGTC;Aptamer Rv:GCTAGACGATATTCGTCCATC, reverse complementary sequence:
GATGGACGAATATCGTCTAGC;Obtained positive monoclonal carries out nucleotide sequencing, and sequencing result shows special with borax
Property the aptamer that combines be made of 82 nucleotide, 5 ' ends are to 3 ' terminal sequences are as follows:
GACATATTCAGTCTGACAGCGGAAGCGGGTCAGTCCAACTCACGGTCTCGCATGCACGGGAGATGGACGAAT
ATCGTCTAGC。
5. the screening technique of the aptamer specifically bound as claimed in claim 3 with borax, which is characterized in that obtain
It also needs to carry out aptamer single stranded DNA secondary structure characterization after aptamers Bor-A01,
Secondary structure is carried out using the aptamer Bor-A01 single strand dna that MFOLD software pair is specifically bound with borax
Prediction;Secondary structure has ring outstanding and stem, Gibbs free energy DG=-15.21.
6. the screening technique of the aptamer specifically bound as claimed in claim 3 with borax, which is characterized in that borax
The preparation of coating antigen includes:
The coating antigen that borax molecule and BSA coupling are obtained to borax by chemical method, for subsequent enzyme-linked oligonucleotides absorption
In measuring method;The preparation situation of coating antigen is judged by ultra-violet absorption spectrum.
7. a kind of be loaded with identifying borax or making for the aptamer specifically bound as described in claim 1 with borax
The kit of standby detection borax.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910371568.7A CN110066804A (en) | 2019-05-06 | 2019-05-06 | A kind of aptamer with borax specific binding |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910371568.7A CN110066804A (en) | 2019-05-06 | 2019-05-06 | A kind of aptamer with borax specific binding |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110066804A true CN110066804A (en) | 2019-07-30 |
Family
ID=67370221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910371568.7A Pending CN110066804A (en) | 2019-05-06 | 2019-05-06 | A kind of aptamer with borax specific binding |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110066804A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110885827A (en) * | 2019-11-26 | 2020-03-17 | 昆明理工大学 | Aptamer specifically bound with vomitoxin, preparation method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107505463A (en) * | 2017-07-17 | 2017-12-22 | 昆明理工大学 | With the aptamer Sf B09 of sodium formaldehyde sulfoxylate specific bond and its application |
CN108251429A (en) * | 2018-03-05 | 2018-07-06 | 昆明理工大学 | A kind of aptamer Met-G02 and its application with acephatemet specific binding |
-
2019
- 2019-05-06 CN CN201910371568.7A patent/CN110066804A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107505463A (en) * | 2017-07-17 | 2017-12-22 | 昆明理工大学 | With the aptamer Sf B09 of sodium formaldehyde sulfoxylate specific bond and its application |
CN108251429A (en) * | 2018-03-05 | 2018-07-06 | 昆明理工大学 | A kind of aptamer Met-G02 and its application with acephatemet specific binding |
Non-Patent Citations (3)
Title |
---|
LE JING等: "A novel borax-specific ssDNA aptamer screened by high-throughput SELEX and its colorimetric assay with aggregation of AuNPs", 《JOURNAL OF FOOD COMPOSITION AND ANALYSIS》 * |
靖 乐: "硼砂相应核酸适配体的筛选及其可视化检测法的研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》 * |
魏强等: "动力学毛细管电泳法求解蛋白质与单链脱氧核糖核苷酸结合的解离常数及可靠性分析", 《色谱》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110885827A (en) * | 2019-11-26 | 2020-03-17 | 昆明理工大学 | Aptamer specifically bound with vomitoxin, preparation method and application |
CN110885827B (en) * | 2019-11-26 | 2022-07-01 | 昆明理工大学 | Aptamer specifically bound with vomitoxin, preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaur et al. | Aptamers in the therapeutics and diagnostics pipelines | |
Yang et al. | Development of a highly specific chemiluminescence aptasensor for sulfamethazine detection in milk based on in vitro selected aptamers | |
JP2674957B2 (en) | Electrochemiluminescence assay | |
Goldman et al. | Selection of phage displayed peptides for the detection of 2, 4, 6-trinitrotoluene in seawater | |
RU2107730C1 (en) | Molecular probe | |
CN103513027B (en) | Establishment of novel ultrasensitiveness ELISA method | |
CN104198721A (en) | Preparation and application of Golgi protein 73 (GP73) antigen silicon-based magnetic bead conjugate | |
CN107505463B (en) | With the aptamer Sf-B09 of sodium formaldehyde sulfoxylate specific bond and its application | |
CN107462714B (en) | With the aptamer Sf-A09 of sodium formaldehyde sulfoxylate specific bond and its application | |
CN110066804A (en) | A kind of aptamer with borax specific binding | |
ES2690783T3 (en) | Screening methods and uses thereof | |
CN105039346B (en) | A kind of aptamer and application with melamine specific bond | |
CN110423754A (en) | Aptamer and utilization SELEX screening technique and application with borax specific binding | |
CN104233474A (en) | Synthetic phage display nano antibody library and application thereof | |
Yuan et al. | Development of single chain variable fragment (scFv) antibodies against Xylella fastidiosa subsp. pauca by phage display | |
CN108251429A (en) | A kind of aptamer Met-G02 and its application with acephatemet specific binding | |
CN104862314B (en) | A kind of and the aptamer of α amanita hemolysin specific bonds and application | |
WO2011014989A1 (en) | Oligonucleotide aptamers targeting at mycobacterium tuberculosis ag85b, preparing method and uses thereof | |
Huang et al. | High-resolution mapping of human norovirus antigens via genomic phage display library selections and deep sequencing | |
Hirose et al. | Strong and Specific Recognition of CAG/CTG Repeat DNA (5’‐dWGCWGCW‐3’) by a Cyclic Pyrrole‐Imidazole Polyamide | |
CN108486119B (en) | Aptamer RhB-F02 specifically bound with rhodamine B and application thereof | |
CN105177009B (en) | A kind of aptamer and application with α-amanita hemolysin specific bond | |
CN105177011B (en) | A kind of aptamer and application with clenbuterol hydrochloride specific bond | |
CN104878015B (en) | A kind of bacterial endotoxin aptamer and its application | |
CN105039347B (en) | A kind of aptamer and application with glyphosate specific bond |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |